NephMadness 2020

NephMadness is a nephrology-focused online interactive medical education activity. It has been an annual program for 8 years and this is the third year that CME/CE credit will be offered for players, and second for MOC! Social media, interactivity, and gamification will teach the latest advances and the most important breakthroughs in nephrology.

There are 8 general nephrology themes (called “regions”) broken down into 4 specific concepts (called “teams”). Teams compete against each other in a single elimination contest. We have selected content experts from each region to make sure the information we present is accurate, unbiased, and interesting. For details, read the explanatory post here.

Access to each NephMadness 2020 region can be found below:

Hyperkalemia Region

Hemodialysis Access Region

Vaccines Region

Ethics Region

Green Nephrology Region

Transplantation Region

Genetics Region

SGLT2 Inhibitors Region

Target Audience

  • Physicians
Method of Participation:
  • Read the 8 “region” summaries that cover the 32 nephrology concept at the AJKD blog here. Earn up to 1.0 credit per region.
  • Complete a bracket with your predictions of what concepts are the most important or most impactful here
  • Participate in social media (using #NephMadness on Twitter, Instagram, Facebook, blog) discussions about these concepts, sharing your opinions of what is the most important or impactful to you in nephrology.
  • Login or create an account to this site
  • Complete the post-test (for only the regions you participated in) 
  • Submit your evaluation 
  • Claim credit (1 region = 1 credit/MOC)
  • Download your certificate

Learning Objectives

After this activity learners will be better able to:

•    Discuss the role for using SGLT2 inhibitors in various forms of kidney disease.
•    Recognize the mechanisms of kidney protection with this class of drugs. 
•    Articulate the environmental impact of providing dialysis care.  
•    Describe the impact of climate change on kidney health.
•    Evaluate the effects of exercise on potassium homeostasis.
•    Describe the novel potassium binding agents for potassium.
•    Recognize the impact of dietary potassium intake on kidney health.
•    Outline the use of live and inactivated vaccines in kidney transplant patients.
•    Discuss options and data for influenza and pneumonia vaccination in patients with ESKD on dialysis.
•    Describe the European and US guidelines for hemodialysis vascular access.
•    Discuss novel percutaneous creation of AV fistulas, and compare them to traditional surgical fistula creation.
•    Discuss the gamut of methods for monitoring allograft function.
•    Explain of the evidence for and against accepting kidney donors who use marijuana.
•    Outline the ethical principles behind policies pushing for more home dialysis.
•    Discuss the ethical principles that are commonly encountered for terminal prognoses with regards to offering dialysis and hospice.
•    Discuss genetic counseling options for patients with cystic kidney disease and nephrolithiasis.
•    Recognize the various inheritance patterns associated with Alport’s syndrome.

Additional information
AttachmentSize
NephMadness 2020 Bracket560.81 KB
Course summary
Available credit: 
  • 8.00 ABIM MOC
  • 8.00 AMA PRA Category 1 Credit™
  • 8.00 Attendance
Course opens: 
03/02/2020
Course expires: 
06/13/2020
Cost:
$0.00
Rating: 
0
Faculty Disclosures:

Harish Seethpathy, MD
Fellow
Massachusetts General Hospital
Boston, MA
Disclosure: Grant Award: Relypsa

Amy Yau, MD
Physician
Mount Sinai Hospital
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Ryann Sohaney, D.O.
Postdoctoral Clinical Researcher
University of Michigan
Ann Arbor, MI
Disclosure: Has no financial relationships with commercial interest(s).

Pascale Khairallah, MD
Fellow
Columbia University
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Swapnil Hiremath, MD, MPH, FASN
Associate Professor
University of Ottawa
Ottawa, ON, Canada
Disclosure: Has no financial relationships with commercial interest(s).

Adrian Whelan, MD, BCh, BAO
Fellow
University of California, San Francisco
San Francisco, CA
Disclosure: Has no financial relationships with commercial interest(s).

Devika Nair, MD, MSCI
Instructor of Medicine
Vanderbilt University Medical Center
Nashville, TN
Disclosure: Has no financial relationships with commercial interest(s).

Bethany Roehm, MD
Nephrology Fellow
Tufts Medical Center
Boston, MA
Disclosure: Has no financial relationships with commercial interest(s).

Meg Jardine, MBBS, PhD
Professor
The George Institute for Global Health
Sydney, Canada
Disclosure: Honorarium to institution: Janssen, CSL, Boehringer Ingelhein, Vifor, Amgen; Research Grant: MSD, AMgen, Eli Lilly

Katherine Barraclough, MBBS, FRACP, PhD
Nephrologist
Melbourne Health
Parkvilee, Victoria
Disclosure: Has no financial relationships with commercial interest(s).

Deborah Clegg, RD, PhD
Associate Dean for Research
Drexel University
Philadelphia, PA
Disclosure: Has no financial relationships with commercial interest(s).

Ibironke Apata, MD
Assistant Professor
Emory University School of Medicine
Atlanta, GA
Disclosure: Has no financial relationships with commercial interest(s).

Monnie Wasse, MD
Professor and Vice Chair of Medicine Director
Rush University Medical Center
Chicago, IL
Disclosure: Honoraria: Avenu Medical, BD

Vinay Nair, DO
Associate Professor of Medicine
Northwell Health
New Hyde Park, NY
Disclosure: Has no financial relationships with commercial interest(s).

Nwamaka Eneanya, MD, MPH
Assistant Professor
University of Pennsylvania
Philadelphia, PA
Disclosure: Has no financial relationships with commercial interest(s).

Michelle Rheault, MD
Associate Professor
University of Minnesota
Minneapolis, MN
Disclosure: Honoraria: Advicenne; Research Funding: Goldfinch Bio, Retrophin, Reata, Genentech

Planning Committee Disclosures:

Matthew Sparks, MD
Assistant Professor
Duke University
Durham, NC
Disclosure: Has no financial relationships with commercial interest(s).

Joel Topf, MD
Director of Research
St. Clair Specialty Physicians, PC
Huntington Woods, MI
Disclosure: Consulting Fee and Dividend: DaVita, Travel: Takeda Oncology

Anna Burgner, MD, MEHP
Associate Professor of Medicine
Vanderbilt University Medical Center
Nashville, TN
Disclosure: Sponsored Research: FibroGen, Bayer, inRegen, AstraZeneca

Samira Farouk, MD, MS, FASN
Assistant Professor
Icahn School of Medicine at Mount Sinai
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Timothy Yau, MD
Assistant Professor of Medicine
Washington University School of Medicine
Saint Louis, MO
Disclosure: Has no financial relationships with commercial interest(s).

Jessica Joseph, MBA
Senior Vice President, Scientific Operations
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Kathryn Troy, MPH
Senior Continuing Medical Education Manager
National Kidney Foundation
New York, NY 
Disclosure: Has no financial relationships with commercial interest(s).

Reviewer Disclosure

Jeff Berns, MD
Professor of Medicine
University of Pennsylvania
Philadelphia, PA
Disclosure: Has no financial relationships with commercial interest(s).

Daniel Weiner, MD, MS
Nephrologist
Tufts Medical Center
Boston, MA
Disclosure: Research: Dialysis Clinic, Inc.; Consulting Fee: Akebia, Janssen; Honoraria: National Kidney Foundation, American Society of Nephrology

James Kaufman, MD
Consultant
New York, NY
Disclosure: Honoraria: National Kidney Foundation

Declaration of Disclosure:

It is the policy of the National Kidney Foundation (NKF) to ensure balance, independence, objectivity, and scientific rigor in all CME/CE activities. Any individual who has control over CME/CE content is required to disclose to learners prior to the activity any relevant financial relationship(s) they may have with commercial interests supporting this activity or whose products or devices are discussed in this activity.  

If, on the basis of information disclosed, a perceived conflict exists, resolution will be achieved based on NKF's Disclosure and Conflict of Interest Policy.

Unlabeled/Investigational Use:

During their presentations, faculty may discuss an unlabeled use or an investigational use not approved for a commercial product. Each faculty member is required to disclose this information to the audience when referring to an unlabeled or investigational use.

In support of improving patient care, the National Kidney Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Physician

The National Kidney Foundation designates this enduring activity for a maximum of 8.0 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
 

Available Credit

  • 8.00 ABIM MOC
  • 8.00 AMA PRA Category 1 Credit™
  • 8.00 Attendance

Price

Cost:
$0.00
Please login or register for a PERC account to take this course.
Disclaimer:

The faculty and National Kidney Foundation (NKF) do not recommend the use of any pharmaceutical, diagnostic test, or device outside of the labeled indications as approved by the FDA. Please refer to the official prescribing information for each product for approved indications, contraindications, and warnings.

Information contained in this NKF educational resource is based upon current data available at the time of publication. Information is intended to help clinicians become aware of new scientific findings and developments.  This NKF educational resource is not intended to set out a preferred standard of care and should not be construed as one. Neither should the information be interpreted as prescribing an exclusive course of management.

Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every healthcare professional making use of information in this NKF educational resource is responsible for interpreting the data as it pertains to clinical decision making in each individual patient.

Required Hardware/software

System Requirements 

For hardware/software and internet connectivity requirements for participation in this CME/CE activity, visit kidney.org/cme and click on System Requirements for Participation.

Contact Information

For any questions concerning this activity, please send an email to CMEinfo@kidney.org or call NKF at 1-800-622-9010.
To view NKF privacy and confidentiality policy as it relates to CME/CE activity, please visit http://www.kidney.org/
For additional professional education resources, contact NKF at 1-800-622-9010 or visit https://www.kidney.org/professionals